Mastodon

Mucaltin Renewal (Tablets) Instructions for Use

ATC Code

R05CA (Expectorants)

Active Substance

Herba Althaeae officinalis (Grouping Name)

Clinical-Pharmacological Group

Herbal preparation with expectorant effect

Pharmacotherapeutic Group

Drugs used for cough and colds; expectorants, excluding combinations with antitussives; expectorants

Pharmacological Action

A herbal preparation. It contains a large amount of polysaccharides. It has expectorant properties.

Due to reflex stimulation, it increases the activity of the ciliated epithelium and the peristalsis of the respiratory bronchioles in combination with increased secretion of the bronchial glands.

Indications

  • Acute and chronic respiratory diseases accompanied by cough with the formation of difficult-to-separate viscous sputum (tracheobronchitis, obstructive bronchitis, pneumonia, bronchiectasis) – as part of complex therapy.

ICD codes

ICD-10 code Indication
J04 Acute laryngitis and tracheitis
J15 Bacterial pneumonia, not elsewhere classified
J20 Acute bronchitis
J37 Chronic laryngitis and laryngotracheitis
J42 Unspecified chronic bronchitis
J47 Bronchiectasis
R05 Cough
ICD-11 code Indication
CA05 Acute laryngitis or tracheitis
CA0G Chronic laryngitis or laryngotracheitis
CA20.1Z Chronic bronchitis, unspecified
CA24 Bronchiectasis
CA40.0Z Bacterial pneumonia, unspecified
CA42.Z Acute bronchitis, unspecified
MD12 Cough

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Determine the dosage individually based on the patient’s age and the severity of the condition.

Administer tablets orally. For adults and children over 12 years, the typical dose is 1-2 tablets taken 3-4 times daily before meals.

The duration of therapy depends on the clinical response. Do not exceed the recommended daily dose.

Adverse Reactions

Possible adverse reactions include allergic reactions such as skin rash, itching, and urticaria.

Gastrointestinal disturbances, including nausea and dyspepsia, may occur. Discontinue use immediately if any severe hypersensitivity reactions develop.

Contraindications

  • Hypersensitivity to Althaea officinalis or any other component of the formulation.
  • Presence of gastric ulcer or duodenal ulcer.
  • Children under 12 years of age.

Use in Pregnancy and Lactation

Use during pregnancy and breastfeeding is possible on the recommendation of a doctor.

Pediatric Use

Contraindicated for use in children under 12 years of age.

Special Precautions

Effect on the ability to drive vehicles and mechanisms

Althaea does not affect the ability to drive vehicles and engage in other potentially hazardous activities that require increased attention and speed of psychomotor reactions.

Drug Interactions

This preparation can be used concomitantly with other agents for treating bronchopulmonary diseases.

Avoid concurrent use with antitussives, particularly those containing codeine, as this suppresses the cough reflex and hinders the clearance of liquefied sputum, increasing the risk of respiratory complications.

Overdose

Symptoms of overdose may include severe nausea, vomiting, and abdominal pain.

Treatment is symptomatic and supportive. There is no specific antidote. Gastric lavage may be considered if ingestion is recent. Ensure adequate hydration.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

Brand (or Active Substance), Marketing Authorisation Holder, Dosage Form

Marketing Authorization Holder

Obnovlenie Pfc, JSC (Russia)

Dosage Form

Bottle OTC Icon Mucaltin Renewal Tablets 50 mg

Dosage Form, Packaging, and Composition

Tablets

Althaea officinalis herb extract 50 mg

10 pcs. – non-cell contour packs (20 pcs.) – cardboard packs (200 pcs.) – Over-the-Counter
10 pcs. – non-cell contour packs (400 pcs.) – transport packaging (4000 pcs.) – for hospitals
10 pcs. – blister contour packs – cardboard packs (10 pcs.) – Over-the-Counter
10 pcs. – blister contour packs (2 pcs.) – cardboard packs (20 pcs.) – Over-the-Counter
10 pcs. – blister contour packs (20 pcs.) – cardboard packs (200 pcs.) – Over-the-Counter

Marketing Authorization Holder

Triangle, LLC (Russia)

Manufactured By

Obnovlenie Pfc, JSC (Russia)

Dosage Form

Bottle OTC Icon Mucaltin Renewal Effervescent tablets 50 mg

Dosage Form, Packaging, and Composition

Effervescent tablets from light gray to brownish-grayish or grayish-brownish in color with inclusions, round flat-cylindrical, with a characteristic odor, with a bevel; marbling and roughness are allowed; the prepared solution is transparent or with slight opalescence, from light grayish to brownish-grayish or grayish-yellow, or grayish-brownish in color, with a characteristic odor.

1 tab.
Althaea officinalis herb (Althaeae officinalis herba) dry extract* 50 mg

* extractant – water (3.6-8.6):1

Excipients : sodium bicarbonate, anhydrous citric acid, adipic acid, povidone K30.

10 pcs. – polypropylene tubes (1) with first opening control – cardboard packs.
20 pcs. – polypropylene tubes (1) with first opening control – cardboard packs.

Marketing Authorization Holder

Medisorb, JSC (Russia)

Dosage Form

Bottle OTC Icon Mucaltin Medisorb Tablets 50 mg: 30 pcs.

Dosage Form, Packaging, and Composition

Tablets from light gray to brownish-gray in color, with inclusions of lighter and darker colors, round, flat-cylindrical, with a bevel and a score, with a characteristic odor.

1 tab.
Althaea officinalis herb extract 50 mg

Excipients : sodium bicarbonate, tartaric acid, calcium stearate.

10 pcs. – blister contour packs (3) – cardboard packs.

Marketing Authorization Holder

Tyumen Chemical and Pharmaceutical Plant, JSC (Russia)

Dosage Form

Bottle OTC Icon Mucaltin-LekT Tablets 50 mg: 10, 20 or 30 pcs.

Dosage Form, Packaging, and Composition

Tablets of round shape, flat-cylindrical, with a bevel and a score on one side, from light gray to brownish-gray in color, with inclusions of darker or lighter particles.

1 tab.
Althaea officinalis herb dry extract (mucaltin dry extract) 50 mg
   With a content of the sum of polysaccharides in terms of glucose 18%

Excipients : tartaric acid – 160 mg, sodium bicarbonate – 87 mg, calcium stearate – 3 mg.

10 pcs. – non-cell contour packs (1) – cardboard packs.
10 pcs. – non-cell contour packs (2) – cardboard packs.
10 pcs. – non-cell contour packs (3) – cardboard packs.
10 pcs. – blister contour packs (1) – cardboard packs.
10 pcs. – blister contour packs (2) – cardboard packs.
10 pcs. – blister contour packs (3) – cardboard packs.

Table of Contents

→ TABLE OF CONTENTS